NCT03263416View on ClinicalTrials.gov

Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up Compared to Standard Follow-up.

NACompletedINTERVENTIONAL
Enrollment

186

Participants

Timeline

Start Date

July 24, 2017

Primary Completion Date

January 25, 2022

Study Completion Date

January 25, 2022

Conditions
Metastatic Solid Tumor
Interventions
OTHER

Dedicated and coordinated follow-up

"* Coordinated follow-up performed by a dedicated nurse with consultations (before treatment initiation and during treatment) and a telephone follow-up during treatment period~* Pharmaceutical conciliation before treatment initiation made by the Center Pharmacist~* Completion of QLQ-C30 and GIRERD questionnaires"

OTHER

Standard follow-up

\- Completion of QLQ-C30 and GIRERD questionnaires

Trial Locations (4)

31059

Institut Claudius Regaud, Toulouse

81000

Clinique Claude Bernard, Albi

81108

Centre Hospitalier Intercommunal Castres Mazamet, Castres

Unknown

Clinique Des Cedres, Cornebarrieu

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT03263416 - Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up Compared to Standard Follow-up. | Biotech Hunter | Biotech Hunter